Clinical Trial Update: Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial of etanercept (Enbrel) in children with systemic onset juvenile rheumatoid arthritis was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Amgen | Conditions: Juvenile Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2019-09-25